- All sections
- G - Physics
- G01N - Investigating or analysing materials by determining their chemical or physical properties
- G01N 33/541 - Double or second antibody
Patent holdings for IPC class G01N 33/541
Total number of patents in this class: 127
10-year publication summary
2
|
8
|
5
|
15
|
18
|
14
|
8
|
8
|
9
|
1
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
F. Hoffmann-La Roche AG | 7958 |
3 |
Roche Diagnostics Operations, Inc. | 1375 |
3 |
Board of Regents, The University of Texas System | 5370 |
3 |
Beckman Coulter, Inc. | 1183 |
3 |
Bio-Rad Laboratories, Inc. | 1592 |
3 |
DiaSorin S.p.A. | 64 |
3 |
Intrinsic Lifesciences LLC | 18 |
3 |
Siemens Healthcare Diagnostics Inc. | 1946 |
3 |
Charles River Laboratories International, Inc | 8 |
3 |
S D Systems, Inc. | 3 |
3 |
Becton, Dickinson and Company | 6712 |
2 |
Arizona Board of Regents, a Body Corporate of The State of Arizona Acting for and on Behalf of Arizona State University | 311 |
2 |
Children's Medical Center Corporation | 1780 |
2 |
Chrome Red Technologies, LLC | 9 |
2 |
The Council of the Queensland Institute of Medical Research | 155 |
2 |
EDP Biotech Corporation | 9 |
2 |
Eli Lilly and Company | 3645 |
2 |
The Governing Council of The University of Toronto, | 1361 |
2 |
IDEXX Laboratories, Inc. | 730 |
2 |
Sekisui Medical Co., Ltd. | 624 |
2 |
Other owners | 77 |